PWM
CVRS

Perigon Wealth Management’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Perigon Wealth Management’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-200
Closed – – 670
2018
Q1 		$0 Hold
200
– – ﹤0.01% 701
2017
Q4 		$0 Hold
200
– – ﹤0.01% 689
2017
Q3 		$0 Buy
+200
New +$335 ﹤0.01% 747

Other funds holding CVRS

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
PVAM
Pacific View Asset Management San Francisco, California $20.8M AUM 20.08% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Perigon Wealth Management's CVRS Position: Q2 2018 in Review

Perigon Wealth Management sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q2 2018, closing a stake of 200 shares.

Perigon Wealth Management first reported a position in CVRS in Q3 2017 and held it in 3 quarters. The position peaked at $0 in Q1 2018. 53 funds tracked by Wall St. Rank hold CVRS as of Q2 2018.

  • Perigon Wealth Management reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q2 2018 after selling out during the quarter.
  • Perigon Wealth Management sold 200 CORINDUS VASCULAR ROBOTICS, INC shares in Q2 2018.
  • Perigon Wealth Management first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q3 2017 and held it in 3 quarters.
  • Perigon Wealth Management's CORINDUS VASCULAR ROBOTICS, INC position peaked at $0 in Q1 2018.
  • 53 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q2 2018.

Based on Perigon Wealth Management's 13F filing for Q2 2018, filed 7 Aug 2018.